Mitochondrial disease
Gene: TXNIP
Included as lactic acidosis is a consistent feature of the condition.Created: 24 Aug 2026, 6:51 p.m. | Last Modified: 24 Aug 2026, 6:51 p.m.
Panel Version: 2.6
PMID 42448226 reports seven families (five independent) with biallelic loss‑of‑function TXNIP variants, describing a multisystemic metabolic disorder that includes adult‑onset cardiomyopathy and skeletal‑muscle weakness. Functional data include loss of TXNIP protein in patient fibroblasts (Western blot), rescue of the cellular phenotype by wild‑type TXNIP re‑expression (PMID 41116060), and a Txnip‑KO mouse model showing metabolic abnormalities that are partially rescued by a low‑carbohydrate diet (PMID 42448226).
PMID 41116060 provides cellular rescue experiments for the homozygous c.642_643insT frameshift variant and describes a consanguineous Turkish family.
PMID 30755400 originally described the three‑sibling Libyan family with the homozygous c.174_175delinsTT null variant, demonstrating segregation and rescue of mitochondrial respiration in patient‑derived cells.Created: 24 Aug 2026, 6:45 p.m. | Last Modified: 24 Aug 2026, 6:45 p.m.
Panel Version: 2.517
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Metabolic disease MONDO:0005066, TXNIP-related
Publications
TXNIP binds and inhibits TXN, controlling its activity. The TXN system is a major cellular system for control of redox state, antioxidant defense, and several signaling pathways. TXNIP can also activate the NLRP3 inflammasome and suppress of the activities of the
nuclear factor (erythroid-derived 2)–like 2 (Nrf2) transcription factor.
PMID 30755400 reports three affected siblings from a consanguineous Libyan family with autosomal recessive congenital lactic acidosis and low serum methionine. 2 of the three siblings have developed normally and appear to be mostly asymptomatic apart from variable hypoglycaemia, while the third had failure the thrive as an infant, slow development, ?autism, and slight muscular hypotonus. All three siblings were homozygous for TXNIP c.174_175delinsTT which creates a stopgain at p.Gly59* (and a missense at p.58). Patient‑derived fibroblasts and myoblasts show impaired pyruvate‑driven mitochondrial respiration that is rescued by TXNIP re‑constitution. However, patient cells showed no difference in cell growth or morphology, and had normal downstream TXN activity while Nrf2 target gene transcripts were upregulated.
PMID 41116060 describes an additional individual with a severe metabolic disease; lactic acidosis, recurrent hypoglycaemia, significant developmental delay, epileptic seizures, and hypotonia. Homozygous for c.642_643insT p.(Ile215Tyrfs*59). Functional studies showed it disrupts SLC7A5-SLC3A2 endocytosis and cellular glucose uptake.
Sources: LiteratureCreated: 14 Nov 2025, 4:24 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Metabolic disease MONDO:0005066, TXNIP-related
Publications
Gene: txnip has been classified as Green List (High Evidence).
Publications for gene: TXNIP were set to 41116060; 30755400
gene: TXNIP was added gene: TXNIP was added to Mitochondrial disease. Sources: Expert Review Green,Literature,Literature Mode of inheritance for gene: TXNIP was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TXNIP were set to 41116060; 30755400 Phenotypes for gene: TXNIP were set to Metabolic disease MONDO:0005066, TXNIP-related